ValueAlpha vs Equidam: Business Valuation Platform Comparison

Overview

Equidam is a valuation platform focused on startups and small-to-medium enterprises. The platform applies five valuation methods and is well known in the startup ecosystem for its Scorecard and Berkus method implementations, which are tailored to early-stage companies that may not yet have significant revenue or cash flow history. Equidam pricing starts around $600 per year or offers per-report options, and the platform integrates valuation outputs into investor pitch materials.

ValueAlpha serves a broader audience of investors, analysts, and business owners who need rigorous, assumption-transparent valuations. At $9.99 per report with no subscription, ValueAlpha delivers discounted cash flow analysis, comparable company matching, precedent transaction data, and AI-driven scenario modeling in bear, base, and bull cases.

Where Equidam Excels

Equidam has carved out a strong niche in the startup valuation space, and it shows in their product design. If you are valuing a pre-revenue or early-revenue startup, Equidam's Scorecard and Berkus methods are specifically designed for that stage. These qualitative approaches account for factors like management team quality, market size, and technology readiness where traditional DCF models may not apply cleanly.

• Scorecard and Berkus methods purpose-built for pre-revenue startups
• Integration with investor pitch decks and fundraising workflows
• Established reputation in the startup and venture capital ecosystem
• Five valuation methods applied simultaneously for cross-validation

Where ValueAlpha Excels

ValueAlpha provides deeper methodology for companies with existing financial data. The platform runs a full DCF analysis with every assumption visible and adjustable, matches against comparable public companies, and pulls in precedent transaction data from real M&A deals. The scenario analysis engine models bear, base, and bull outcomes so you can understand the range of possible valuations rather than relying on a single point estimate.

• Precedent transaction analysis using real M&A deal data
• Bear, base, and bull scenario modeling for stress-testing valuations
• AI-powered insights that identify company-specific risks and opportunities
• Transparent DCF assumptions you can inspect and modify
• Lower cost per report at $9.99 with no annual commitment

Pricing Comparison

Equidam's annual plan costs approximately $600 per year, with some per-report options also available. This works well for founders or advisors who anticipate needing multiple valuations throughout the year, particularly during fundraising rounds.

ValueAlpha charges $9.99 per report with no subscription. For someone who needs one or a handful of valuations, this pay-as-you-go model is significantly more economical. Even if you run dozens of reports per year, the total cost remains well below a typical annual subscription.

Who Should Choose Equidam

Equidam is a strong choice if you are valuing a pre-revenue startup where traditional financial models have limited applicability, if you need valuation outputs formatted for investor pitch decks, or if you operate within the venture capital ecosystem and value Equidam's startup-specific methodology.

Who Should Choose ValueAlpha

ValueAlpha is the better fit if you need a rigorous DCF analysis with full transparency into every assumption, if you want scenario modeling across multiple cases, if you value precedent transaction data alongside comparable company analysis, or if you prefer a per-report pricing model that does not require an annual subscription commitment.